Pulmonary Regurgitation

Respiratory
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

I
IQVIANC - Durham
1 program
trans catheter heart valve replacementN/A1 trial
Active Trials
NCT02846753Unknown84Est. Dec 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
IQVIAtrans catheter heart valve replacement

Clinical Trials (1)

Total enrollment: 84 patients across 1 trials

NCT02846753IQVIAtrans catheter heart valve replacement

Implantation of the Venus P-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts

Start: Aug 2016Est. completion: Dec 202484 patients
N/AUnknown

Related Jobs in Respiratory

Regional Gene Therapy Consultant - Upper Midwest (IL/WI/MN)

Krystal Biotech
Yesterday
$185K - $215K/yr

Regional Gene Therapy Consultant - Southwest (CO/AZ/NM/UT)

Krystal Biotech
Yesterday
$185K - $215K/yr

Product Manager Oncology (Lung)

AstraZeneca
Poland - Warsaw
2d ago

Marketing Manager (Respiratory) - Finland - Nordic Marketing Company

AstraZeneca
Finland - Espoo
2d ago

Ausbildung zum Pharmakanten (m/w/d)

Ferring Pharmaceuticals
Kiel, Germany
2d ago

Sales Rep Neurology Region Leipzig, Halle, Gera, Jena, Weimar DE_G2M110105 - befristet bis 31.03.2027 (all genders)

Sanofi
Berlin
2d ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Asthma(578)Pulmonary Disease, Chronic Obstructive(396)Chronic Obstructive Pulmonary Disease(157)COPD(99)Idiopathic Pulmonary Fibrosis(96)Chronic Obstructive Pulmonary Disease (COPD)(51)Respiratory Syncytial Virus Infections(45)Pulmonary Embolism(30)Severe Asthma(27)Lung Diseases, Interstitial(20)